NBTX (Nanobiotix S.A. American Depositary Shares) Stock Analysis - Hedge Fund Holdings

Nanobiotix S.A. American Depositary Shares (NBTX) is a publicly traded Healthcare sector company. As of May 21, 2026, NBTX trades at $40.16 with a market cap of $2.40B and a P/E ratio of 0.00. NBTX moved -7.86% today. Year to date, NBTX is +106.61%; over the trailing twelve months it is +1018.13%. Its 52-week range spans $2.76 to $57.14. Analyst consensus is strong buy with an average price target of $34.33. Rallies surfaces NBTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns NBTX stock?

Rallies tracks hedge fund and 13F ownership for NBTX, including fund holders, share counts, and position changes when data is available.

NBTX Key Metrics

Key financial metrics for NBTX
MetricValue
Price$40.16
Market Cap$2.40B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$57.14
52-Week Low$2.76
Volume2.00K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NBTX News

NBTX Analyst Consensus

4 analysts cover NBTX: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.33.

Common questions about NBTX

Who owns NBTX stock?
Rallies tracks hedge fund and 13F ownership for NBTX, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for NBTX?
Yes. Rallies tracks hedge fund and 13F ownership data for NBTX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NBTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NBTX. It does not provide personalized investment advice.
NBTX

NBTX